Autolus Therapeutics

AI Score

0
XX

Unlock

2.19
-0.07 (-3.10%)
At close: Jan 28, 2025, 1:49 PM

Autolus Therapeutics Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2020Sep 30, 2020
License Revenue 0 10.10M 0 242.00K
License Revenue Growth -100.00% n/a -100.00% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
United States Revenue 1.35M 6.19M 1.51M
United States Revenue Growth -78.17% +311.02% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016
Selling, General, and Administrative Revenue 27.33M 21.90M 16.37M 13.95M 10.61M 11.12M 9.28M 7.41M 8.23M 8.27M 7.99M 7.59M 8.30M 7.24M 8.74M 9.01M 9.84M 8.51M 7.61M 9.92M 8.61M 11.37M 9.56M 7.59M 7.27M 6.80M 4.33M 2.89M 2.89M 1.66M 1.66M
Selling, General, and Administrative Revenue Growth +24.78% +33.79% +17.33% +31.50% -4.59% +19.80% +25.26% -9.95% -0.46% +3.53% +5.22% -8.53% +14.67% -17.18% -2.98% -8.50% +15.68% +11.75% -23.25% +15.29% -24.32% +18.98% +25.85% +4.40% +6.91% +57.11% +50.03% n/a +73.49% n/a n/a
Research and Development Revenue 40.32M 36.61M 30.67M 25.16M 37.24M 36.74M 31.34M 32.19M 37.63M 38.21M 33.96M 39.63M 32.29M 32.13M 30.73M 38.73M 33.55M 31.33M 31.29M 29.37M 27.31M 26.17M 22.57M 17.71M 10.15M 8.86M 11.69M 4.60M 4.60M 3.51M 3.51M
Research and Development Revenue Growth +10.14% +19.37% +21.91% -32.44% +1.35% +17.22% -2.62% -14.47% -1.52% +12.51% -14.31% +22.74% +0.50% +4.56% -20.65% +15.45% +7.08% +0.13% +6.53% +7.54% +4.34% +15.99% +27.39% +74.53% +14.51% -24.20% +154.17% n/a +31.20% n/a n/a

Create Price Alert on AUTL

Your price alert will notify you when the stock price is above 2.19.

Add to Watchlist